Jian Xin Yang
Chief Executive Officer bei CSTONE PHARMACEUTICALS
Vermögen: 2 Mio $ am 31.03.2024
Profil
Jian Xin Yang is currently the Chief Executive Officer & Executive Director at CStone Pharmaceuticals Co. Ltd.
Prior to this, he held the position of Medical Director at Labcorp Drug Development, Inc. from 2011 to 2014.
He then served as the Senior VP & Head-Clinical Development at BeiGene Ltd.
from 2014 to 2016.
Dr. Yang graduated from Nanjing Medical University in 1988 with a graduate degree and from Hubei University of Science & Technology in 1985 with an undergraduate degree.
Bekannte Unternehmensbeteiligungen
Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
---|---|---|---|---|
CSTONE PHARMACEUTICALS
1,23% | 24.04.2024 | 15 834 256 ( 1,23% ) | 2 Mio $ | 31.03.2024 |
Aktive Positionen von Jian Xin Yang
Unternehmen | Position | Beginn |
---|---|---|
CSTONE PHARMACEUTICALS | Chief Executive Officer | 25.08.2022 |
Ehemalige bekannte Positionen von Jian Xin Yang
Unternehmen | Position | Ende |
---|---|---|
BEIGENE, LTD. | Chief Tech/Sci/R&D Officer | 01.12.2016 |
COVANCE INC. | Chief Tech/Sci/R&D Officer | 01.07.2014 |
Ausbildung von Jian Xin Yang
Nanjing Medical University | Graduate Degree |
Hubei University of Science & Technology | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Börsennotierte Unternehmen | 2 |
---|---|
BEIGENE, LTD. | Health Technology |
CSTONE PHARMACEUTICALS | Health Technology |
Private Unternehmen | 1 |
---|---|
Labcorp Drug Development, Inc.
Labcorp Drug Development, Inc. Pharmaceuticals: MajorHealth Technology Covance, Inc. operates as a contract research organization and drug development company. Its services include research, lead optimization, analysis services, safety assessment and drug safety testing, consulting and partnering, clinical development, informatics, clinical testing, commercialization, and manufacturing support. The company was founded on November 12, 1996 and is headquartered in Princeton, NJ. | Health Technology |